Searched for
ZYDUS REGULATORY UPDATE
Zydus gets 6 observations from USFDA for API unitZydus Lifesciences on Saturday said the US health regulator has issued six observations after inspecting its Gujarat-based API manufacturin...26 Apr, 2025, 03.49 PM IST- China’s biotech is redrawing the global pharma map; what India can learnAmerican biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...16 Mar, 2025, 10.12 AM IST
- Zydus Lifesciences joins hands with CVS Caremark for diabetes drugs template formularyZydus Lifesciences Ltd enters an agreement with CVS Caremark to add Zituvio, Zituvimet, and Zituvimet XR tablets for diabetes treatment to ...07 Jan, 2025, 02.16 PM IST
- Zydus barred from selling cancer biosimilar, for nowThe Delhi High Court has temporarily barred Zydus Lifesciences from selling its breast cancer drug Sigrima, a biosimilar of Roche's Perjeta...10 Jul, 2024, 11.56 PM IST
- COVID-19: Corbevax, Covovax, Molnupiravir approved for emergency useUnion Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's C...28 Dec, 2021, 12.13 PM IST
- Government panel recommends EUA for COVID-19 vaccines Covovax, Corbevax and anti-Covid pill molnupiravirThe SEC on COVID-19 of the CDSCO, which reviewed the emergency use authorisation (EUA) applications of Serum Institute of India (SII) for t...28 Dec, 2021, 10.59 AM IST
- Tackling COVID-19 vaccine management to take the world back to normal03 Nov, 2021, 02.20 PM IST
- India needs new vaccine launches to meet targetsThe government had in a presentation in May estimated that 216 crore vaccines will be available in the country between August and December.12 Aug, 2021, 06.17 PM IST
- Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19 vaccineThe Phase-II study of the vaccine, ZyCoV-D, had been conducted in over 1,000 healthy adult volunteers as part of the adaptive Phase-I and I...24 Dec, 2020, 10.00 PM IST
- India biggest buyer of COVID-19 vaccine with 1.6 bn doses, experts say this could cover 60% populationIndia has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the US company Novavax and 1...04 Dec, 2020, 08.17 PM IST
- Search for vaccines hots up as Covid-19 continues to spread and wreak havoc around the worldOxford University and AstraZeneca will be sharing their data from phase-I trial of their much-touted Covid-19 vaccine candidate on July 20....20 Jul, 2020, 07.00 PM IST
- DCGI gives nod to Hetero Labs and Cipla to manufacture and market remdesivirThe emergency approval is given to an unapproved therapy for compassionate use provided drug companies share the clinical data of the drug ...20 Jun, 2020, 11.38 PM IST
- Drug regulator steps up monitoring of ranitidineThe US FDA announced an update of testing of NDMA in ranitidine, warning manufacturers not to use a high-temperature test for NDMA as it ge...14 Oct, 2019, 07.59 AM IST
- Top drug makers like Sun Pharma, Torrent, Cipla working on quality standards at manufacturing facilitiesArch rivals are grouping to look for a lasting solution to what external subject experts call “deeply ingrained culture issue”.20 Feb, 2016, 06.19 AM IST
- How Dr Reddy’s is rebooting its biosimilars playDr Reddy’s was among the first to race off the blocks with four launches in India about as many years. But things have slowed since.29 Sep, 2015, 02.51 AM IST
- We hope to launch 2 original drugs by 2020: Cadila chairman Pankaj PatelIn biosimilars, EU has already laid out the path, the US has issued many guidelines and the pathway there is evolving rapidly.10 Dec, 2014, 12.14 PM IST
- Many deals didn’t meet our investment criteria: Chrys CapitalIn conversation with ET , Mr Kaul, managing director, ChrysCapital discusses the changing landscape of Indian pharma and the firm’s investm...21 Sep, 2010, 12.59 AM IST
Load More
